11 unknown. 11 Phase 2, 4 Phase 3, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 11 | Unknown 11 |
| Phase 3 | 4 | Unknown 4 |
| Phase 1 | 2 | Unknown 2 |
Follow COVID: new trials by email Literature Review of COVID trials Research Report on COVID
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Subcutaneous Ivermectin With or Without Zinc in COVID-19 Patients Ivermectin Injectable Solution, Injectable Placebo, Zinc - Coronavirus Infection, COVID | Phase 1 / Phase 2 | Unknown | Sohaib Ashraf | 180 | 2020-11-14 | 2021-02-17 |
| P2Et Extract in the Symptomatic Treatment of Subjects With COVID-19 P2Et (Caesalpinia spinosa extract), Placebo - COVID, Coronavirus Infection | Phase 2 / Phase 3 | Unknown | Hospital Universitario San Ignacio | 100 | 2020-09-30 | 2021-08-10 |
| The Açaí Berry COVID-19 Anti-Inflammation Trial Açaí palm berry extract - natural product, Placebo - COVID | Phase 2 | Unknown | University Health Network, Toronto | 480 | 2020-08-04 | 2022-05-31 |
| Sofosbuvir in Treatment of COVID 19 sofosbuvir, Sofosbuvir ledipsavir, Daclatasvir - COVID | Phase 2 / Phase 3 | Unknown | Tanta University | 60 | 2020-08-01 | 2020-12-08 |
| An Adaptive Clinical Trial of Antivirals for COVID-19 Infection Favipiravir - COVID | Phase 2 | Unknown | Bayside Health | 190 | 2020-07-30 | 2021-10-07 |
| Pulmozyme to Improve COVID-19 ARDS Outcomes Pulmozyme, Placebo - COVID | Phase 2 | Unknown | Boston Children's Hospital | 60 | 2020-07-05 | 2021-12-17 |
| Ivermectin in Treatment of COVID-19 Ivermectin - COVID | Phase 2 / Phase 3 | Unknown | Zagazig University | 100 | 2020-05-31 | 2020-06-24 |
| Effectiveness and Safety of Convalescent Plasma Therapy on COVID-19 Patients With Acute Respiratory Distress Syndrome Convalescent plasma, Standard of care - COVID, Acute Respiratory Distress Syndrome | Phase 2 / Phase 3 | Unknown | Universitas Indonesia | 60 | 2020-05-18 | 2020-08-18 |
| Low Dose Radiotherapy in COVID-19 Pneumonia Low Dose Radiotherapy - COVID, SARS (Severe Acute Respiratory Syndrome) | Phase 1 / Phase 2 | Unknown | Shahid Beheshti University of Medical Sciences | 5 | 2020-05-04 | 2020-11-10 |
| Senicapoc in COVID-19 Patients With Severe Respiratory Insufficiency Senicapoc - ARDS, Human, COVID | Phase 2 | Unknown | University of Aarhus | 46 | 2020-04-24 | 2020-10-20 |
| Oxygen-Ozone as Adjuvant Treatment in Early Control of COVID-19 Progression and Modulation of the Gut Microbial Flora Oxygen-ozone therapy, probiotic supplementation and Standard of care, SivoMixx (200 billion), Azithromycin - COVID, SARS-CoV 2 | Phase 2 | Unknown | Roberto Poscia MD, PhD | 152 | 2020-03-26 | 2020-04-28 |
Coronavirus Infections (4) · COVID-19 (3) · Respiratory Distress Syndrome (2) · Pneumonia (1) · Pneumonia, Viral (1) · Severe Acute Respiratory Syndrome (1)
Lung Diseases (7) · Respiratory Tract Diseases (7) · Infections (6) · Coronaviridae Infections (5) · Nidovirales Infections (5) · RNA Virus Infections (5) · Respiratory Tract Infections (5) · Virus Diseases (5) · Pneumonia (4) · Pneumonia, Viral (3) · Respiration Disorders (2) · Coronavirus Infections (1)
Ivermectin (2) · Standard of Care (2) · Azithromycin (1) · Hydroxychloroquine (1) · Radiotherapy (1) · Saline Solution (1) · Sofosbuvir (1) · Zinc (1) · daclatasvir (1) · dornase alfa (1) · favipiravir (1) · senicapoc (1)
Bayside Health (1) · Boston Children's Hospital (1) · Hospital Universitario San Ignacio (1) · Roberto Poscia MD, PhD (1) · Shahid Beheshti University of Medical Sciences (1) · Sohaib Ashraf (1) · Tanta University (1) · Universitas Indonesia (1) · University Health Network, Toronto (1) · University of Aarhus (1) · Zagazig University (1)
Egypt (2) · Australia (1) · Brazil (1) · Canada (1) · Colombia (1) · Denmark (1) · Indonesia (1) · Iran (1) · Italy (1) · Pakistan (1) · United States (1)
Ahmad Ameri, Prof. (1) · Ana Andreazza, PhD (1) · Andri MT Lubis, MD, PhD (1) · Asger Granfeldt, MD, PhD (1) · Bodil S Rasmussen, MD, PhD (1) · Francesco Pugliese, MD, PhD (1) · Klaus T Kristiansen, MD (1) · Marwa Salama, Consultant (1) · Michael Farkouh, MD, MSc (1) · Moneeb Ashraf, MBBS (1) · Muhammad Ashraf, PhD (1) · Nazanin Rahnama, M.D. (1) · Shoaib Ashraf, PhD (1) · Sohaib Ashraf, MBBS (1) · Steffen Christensen, MD (1)
PMID 32150360, PMID 32228825, PMID 32303365, PMID 33050947, PMID 34473343, PMID 34488858, PMID 36160152